Histopathologic PD-L1 Tumor Expression and Prognostic Significance in Nonmelanoma Skin Cancers: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histopathologic PD-L1 Tumor Expression and Prognostic Significance in Nonmelanoma Skin Cancers: A Systematic Review

Published:2020-08-24 Issue:5 Volume:43 Page:321-330
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Lehmer Larisa,Choi Franchesca,Kraus Christina,Shiu Jessica,de Feraudy Sebastien,Elsensohn Ashley

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Pathology and Forensic Medicine

Reference65 articles.

1. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations;Gong;J Immunother Cancer.,2018

2. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer;Topalian;N Engl J Med.,2012

3. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer;Rizvi;Science.,2015

4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration;Liberati;BMJ.,2009

5. Association between programmed death ligand 1 expression in patients with basal cell carcinomas and the number of treatment modalities;Chang;JAMA Dermatol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs;Dermatology Practical & Conceptual;2024-07-31

2. Immunotherapy for keratinocyte cancers. Part I: Immune-related epidemiology, risk factors, pathogenesis, and immunotherapy management of keratinocyte cancers;Journal of the American Academy of Dermatology;2023-06

3. Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma;Bosnian Journal of Basic Medical Sciences;2022-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3